Colloids for Nanobiotechnology: Synthesis, Characterization and Potential Applications, Volume 17, offers a range of perspectives on emerging nano-inspired colloidal applications. With an emphasis on biomedical and environmental opportunities and challenges, the book outlines how nanotechnology is being used to increase the uses and impact of colloid science. Nanotechnology offers new horizons for colloidal research and synthesis routes that allow for the production of highly reproducible and defined materials. This book presents new characterization methods and a fundamental understanding of basic physicochemical, physical and chemical properties.
Reihe
Sprache
Verlagsort
Verlagsgruppe
Zielgruppe
Für Beruf und Forschung
Researchers in materials science, colloid chemistry and biomedicine
Maße
Höhe: 235 mm
Breite: 191 mm
Gewicht
ISBN-13
978-0-08-102828-5 (9780081028285)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Wolfgang J. Parak is Professor at the Department of Physics and Chemistry at Hamburg University, Germany. He is an advisory board member of the Elsevier journal, Journal of Colloid and Interface Science. Neus Feliu is a Research Fellow at the Department of Physics and Chemistry at Hamburg University, Germany, and the Department of Laboratory Medicine (LABMED), Karolinska Institutet, Sweden. Her research is focused on engineered nanomaterials for biomedical applications.
Herausgeber*in
Department of Physics and Chemistry, Hamburg University, Germany
Department of Physics and Chemistry, Hamburg University, Germany
1. Colloids for Nanobiotechnology - An Introductio2. Surface-enhanced Raman scattering (SERS) sensing of nucleic acids3. Energy transfer with nanoparticles for in vitro diagnostic4. Nanoparticles for imaging application5. Colloidal nanoparticles as pharmaceutical agent6. Fluorescent nanoparticles for sensin7. Two-dimensional nanoparticles for the delivery of anticancer drugs and cancer therapy8. Engineered polymeric nanovehicles for drug deliver9. Polymer-based nanoparticles for biomedical applications10. Targeted delivery of nanoparticles11. Nanoparticles for immunotherap12. Targeted hyperthermia with plasmonic nanoparticles13. Current challenges and coming opportunities in nanoparticle risk assessment
